These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14533035)

  • 1. Severe allergic blepharoconjunctivitis induced by a dye for eyelashes and eyebrows.
    Kaiserman I
    Ocul Immunol Inflamm; 2003 Jun; 11(2):149-51. PubMed ID: 14533035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe blepharoconjunctivitis induced by a peeling mask containing trichloroacetic acid.
    Kaiserman I; Kaiserman N
    Ocul Immunol Inflamm; 2005; 13(2-3):257-9. PubMed ID: 16019688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic contact dermatitis presenting as severe and persistent blepharoconjunctivitis and centrofacial oedema after dyeing of eyelashes.
    Vogel TA; Coenraads PJ; Schuttelaar ML
    Contact Dermatitis; 2014 Nov; 71(5):304-6. PubMed ID: 25345792
    [No Abstract]   [Full Text] [Related]  

  • 4. Contact blepharoconjunctivitis due to black henna--a case report.
    Pas-Wyroślak A; Wiszniewska M; Kręcisz B; Swierczyńska-Machura D; Pałczyński C; Walusiak-Skorupa J
    Int J Occup Med Environ Health; 2012 Jun; 25(2):196-9. PubMed ID: 22492286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
    Torkildsen GL; Cockrum P; Meier E; Hammonds WM; Silverstein B; Silverstein S
    Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular sensitivity in allergic blepharoconjunctivitis due to phenylephrine eye drops.
    Geyer O; Neudorfer M; Lazar M; Dayan M; Mozes E
    Graefes Arch Clin Exp Ophthalmol; 1993 Dec; 231(12):748-50. PubMed ID: 8299985
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
    Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR;
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe eyelid allergic contact dermatitis secondary to eyelash tint: two case reports.
    Ali L; Foulds JS; Abdul Ghaffar S
    Contact Dermatitis; 2017 Jul; 77(1):59-60. PubMed ID: 28612445
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostics and new developments in the treatment of ocular allergies.
    Kari O; Saari KM
    Curr Allergy Asthma Rep; 2012 Jun; 12(3):232-9. PubMed ID: 22382607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic blepharoconjunctivitis due to phenylephrine.
    Geyer O; Yust I; Lazar M
    J Ocul Pharmacol; 1988; 4(2):123-6. PubMed ID: 3171335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal abnormalities in the NC/Nga mouse: an atopic dermatitis model.
    Ebihara N; Funaki T; Matsuda H; Okumura K; Murakami A; Ra C
    Cornea; 2008 Sep; 27(8):923-9. PubMed ID: 18724155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model.
    Spangler DL; Bensch G; Berdy GJ
    Clin Ther; 2001 Aug; 23(8):1272-80. PubMed ID: 11558863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of three antiallergic eyedrops in a specific conjunctival provocation test: mequitazine, levocabastine and dexamethasone].
    Richard C; Bibas P; Lablache-Combier M; Allaire C
    J Fr Ophtalmol; 2005 Mar; 28(3):244-50. PubMed ID: 15883488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model.
    Friedlaender MH; Harris J; LaVallee N; Russell H; Shilstone J
    Ophthalmology; 2000 Dec; 107(12):2152-7. PubMed ID: 11097587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety of topical pimecrolimus and topical tacrolimus in atopic blepharoconjunctivitis.
    Kiiski V; Remitz A; Reitamo S; Mandelin J; Kari O
    JAMA Dermatol; 2014 May; 150(5):571-3. PubMed ID: 24500107
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study.
    Virtanen HM; Reitamo S; Kari M; Kari O
    Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model.
    Lanier BQ; Finegold I; D'Arienzo P; Granet D; Epstein AB; Ledgerwood GL
    Curr Med Res Opin; 2004 Aug; 20(8):1227-33. PubMed ID: 15324525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atopic keratoconjunctivitis with corneal ulcer. Case report.
    Zemba M; Burcea M; Camburu G
    Rom J Ophthalmol; 2016; 60(3):200-206. PubMed ID: 29450349
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.
    Crampton HJ
    Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phthiriasis palpebrarum: an unusual blepharoconjunctivitis.
    Lin YC; Kao SC; Kau HC; Hsu WM; Tsai CC
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):498-500. PubMed ID: 12523816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.